Levorphanol shows a high rate of [[psychotomimetic]] [[side effect]]s such as [[hallucination]]s and [[delirium]], which have been attributed to by its binding to and activation of the KOR.<ref name="BrueraPortenoy2009">{{cite book|author1=Eduardo D. Bruera|author2=Russell K. Portenoy|title=Cancer Pain: Assessment and Management|url=https://books.google.com/books?id=2TJ-_oECXM4C&pg=PA215|date=12 October 2009|publisher=Cambridge University Press| isbn=978-0-521-87927-9| pages=215â€“}}</ref> At the same time however, activation of this receptor as well as of the DOR have been determined to contribute to its analgesic effects.<ref name="BrueraPortenoy2009" />
